Treatment decisions and survival for people with small-cell lung cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/bjc2013812.pdf
Reference19 articles.
1. Burgers JA, Arance A, Ashcroft L, Hodgetts J, Lomax L, Thatcher N (2002) Identical chemotherapy schedules given on and off trial protocol in small cell lung cancer response and survival results. Br J Cancer 87: 562–566.
2. Charlson ME, Pompei P, Ales KL, Mackenzie CR (1987) A new method of classifying prognostic co-morbidity in longitudinal-studies—development and validation. J Chronic Dis 40: 373–383.
3. Elliss-Brookes L, McPhail S, Ives A, Greenslade M, Shelton J, Hiom S, Richards M (2012) Routes to diagnosis for cancer—determining the patient journey using multiple routine data sets. Br J Cancer 107: 1220–1226.
4. Fukuoka M, Furuse K, Saijo N, Nishiwaki Y, Ikegami H, Tamura T, Shimoyama M, Suemasu K (1991) Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. J Natl Cancer Inst 83: 855–861.
5. Health and social care information centre (2013) National Lung Cancer Audit [Online]. Available at: http://www.hscic.gov.uk/lung (accessed 7th August 2013).
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance;Acta Biochimica et Biophysica Sinica;2023-05-01
2. Treatment patterns and burden of myelosuppression for patients with small cell lung cancer: A SEER‐medicare study;Cancer Treatment and Research Communications;2022
3. Box-Behnken Design Optimization of Etoposide Loaded Nanoemulsion: Formulation Development, Cellular Uptake Analysis and Pharmacokinetic Evaluation;Science of Advanced Materials;2021-09-01
4. LncRNA MANCR positively affects the malignant progression of lung adenocarcinoma;BMC Pulmonary Medicine;2021-08-21
5. Antitumor Effects of Carvacrol and Thymol: A Systematic Review;Frontiers in Pharmacology;2021-07-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3